Eyetech

Eyetech Inc. is a biotechnology company that develops products for the treatment of retinal vision-threatening conditions. It offers Macugen, a pegaptanib sodium injection/anti-VEGF inhibitor used to treat neovascular age-related macular degeneration. The company also provides the Macugen Access Program to assist patients with reimbursement. It markets and sells Macugen in the United States. Eyetech Inc. was founded in 2008 and is headquartered in Cedar Knolls, New Jersey. As of February 13, 2012, Eyetech Inc. operates as a subsidiary of Valeant Pharmaceuticals International.